| Secondary |
| Adult T-cell Lymphoma/leukaemia |
17.2% |
| Constipation |
13.8% |
| Product Used For Unknown Indication |
8.8% |
| Drug Use For Unknown Indication |
8.0% |
| Prophylaxis |
5.7% |
| Parkinson's Disease |
5.6% |
| Hypertension |
5.5% |
| Insomnia |
4.3% |
| Gastritis |
3.8% |
| Wound Complication |
3.5% |
| Antifungal Prophylaxis |
2.9% |
| Hyperlipidaemia |
2.6% |
| Cancer Pain |
2.5% |
| Gastric Cancer |
2.5% |
| Rectal Cancer Recurrent |
2.4% |
| Pneumonia |
2.3% |
| Back Pain |
2.1% |
| Infection |
2.1% |
| Pain |
2.1% |
| Diabetes Mellitus |
2.0% |
|
| White Blood Cell Count Decreased |
10.4% |
| Hepatic Function Abnormal |
8.3% |
| Prostate Cancer |
8.3% |
| Interstitial Lung Disease |
7.3% |
| Deafness Neurosensory |
6.3% |
| Hepatitis Acute |
6.3% |
| Sepsis |
6.3% |
| Stomatitis |
6.3% |
| Pneumonia |
5.2% |
| Pyrexia |
5.2% |
| Abdominal Pain Upper |
4.2% |
| Stevens-johnson Syndrome |
4.2% |
| Aspartate Aminotransferase Increased |
3.1% |
| Liver Disorder |
3.1% |
| Oedema Peripheral |
3.1% |
| Platelet Count Decreased |
3.1% |
| Prothrombin Time Prolonged |
3.1% |
| Coronary Artery Disease |
2.1% |
| Dizziness |
2.1% |
| Drug-induced Liver Injury |
2.1% |
|
| Concomitant |
| Prophylaxis |
15.9% |
| Product Used For Unknown Indication |
14.0% |
| Constipation |
14.0% |
| Hypertension |
8.0% |
| Drug Use For Unknown Indication |
7.6% |
| Cancer Pain |
5.9% |
| Insomnia |
4.7% |
| Rheumatoid Arthritis |
3.9% |
| Multiple Myeloma |
3.7% |
| Pain |
3.7% |
| Gastritis |
2.9% |
| Hepatitis C |
2.6% |
| Diabetes Mellitus |
2.2% |
| Depression |
1.8% |
| Schizophrenia |
1.7% |
| Chronic Hepatitis C |
1.6% |
| Colorectal Cancer |
1.5% |
| Renal Cell Carcinoma |
1.5% |
| Nausea |
1.5% |
| Metastatic Renal Cell Carcinoma |
1.4% |
|
| White Blood Cell Count Decreased |
14.0% |
| Interstitial Lung Disease |
10.2% |
| Pyrexia |
8.3% |
| Vomiting |
6.9% |
| Platelet Count Decreased |
6.7% |
| Pneumonia |
6.4% |
| Hepatic Function Abnormal |
4.8% |
| Rash |
4.4% |
| Renal Impairment |
3.9% |
| White Blood Cell Count Increased |
3.7% |
| Sepsis |
3.5% |
| Thrombocytopenia |
3.5% |
| Liver Disorder |
3.3% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
3.2% |
| Anaemia |
3.1% |
| Decreased Appetite |
2.9% |
| Malaise |
2.8% |
| Stomatitis |
2.8% |
| Nausea |
2.8% |
| Neutrophil Count Decreased |
2.6% |
|
| Interacting |
| Product Used For Unknown Indication |
26.7% |
| Hypertension |
13.3% |
| Constipation |
6.7% |
| Delirium |
6.7% |
| Gastrooesophageal Reflux Disease |
6.7% |
| Ventricular Extrasystoles |
6.7% |
| Atrial Fibrillation |
3.3% |
| Back Pain |
3.3% |
| C-reactive Protein Increased |
3.3% |
| Gastritis |
3.3% |
| Oedema |
3.3% |
| Pain |
3.3% |
| Pneumonia |
3.3% |
| Pyrexia |
3.3% |
| Seasonal Allergy |
3.3% |
| Urinary Tract Infection |
3.3% |
|
| Dyspnoea |
40.0% |
| Cerebral Infarction |
20.0% |
| Drug Prescribing Error |
20.0% |
| Liver Disorder |
20.0% |
|
